Evidence map›Paper›PMID 42652293›Full record

Observational studyInternational journal of environmental research and public health2026

A Tale of Two Cohorts: Comparing HPV Vaccination Barriers and Facilitators Among HIV-Negative and HIV-Positive Women in Tennessee.

Alina Cernasev, Karissa Cliff, Emily Nagel, Hunter Smith, Alex Johnson, Tracy M Hagemann

Abstract readObservational StudyComparative Study
In one paragraph

Observational study in International journal of environmental research and public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Alina CernasevDepartment of Clinical Pharmacy and Translational Sciences, College of Pharmacy, University of Tennessee Health Science, Nashville, TN 37211, USA.ORCID 0000-0001-9627-9541
Karissa CliffDepartment of Clinical Pharmacy and Translational Sciences, College of Pharmacy, University of Tennessee Health Science, Nashville, TN 37211, USA.ORCID 0009-0005-6060-0037
Emily NagelDepartment of Clinical Pharmacy and Translational Sciences, College of Pharmacy, University of Tennessee Health Science, Nashville, TN 37211, USA.
Hunter SmithDepartment of Clinical Pharmacy and Translational Sciences, College of Pharmacy, University of Tennessee Health Science, Nashville, TN 37211, USA.ORCID 0009-0000-5623-0583
Alex JohnsonAmbulatory Pharmacy, University of Tennessee Medical Center, Knoxville, TN 37920, USA.
Tracy M HagemannDepartment of Clinical Pharmacy and Translational Sciences, College of Pharmacy, University of Tennessee Health Science, Nashville, TN 37211, USA.ORCID 0000-0002-5715-9173

Funding

Merck Sharp Dohme (US) A24-1019-001
6 · The paper itself

Abstract

backgroundHuman papillomavirus (HPV) continues to cause an estimated 4000 preventable cancer deaths each year in the United States. Given the prevalence of HPV-related disease and suboptimal vaccination rates, this study explores perceptions of HPV vaccination among HIV-negative females and females living with HIV in Tennessee.

methodsThis prospective, observational qualitative study consisted of narrative interviews which were conducted with HIV-negative and HIV-positive participants, focusing on their perceptions of HPV and its vaccine. Interviews were conducted by phone, and the verbatim transcripts were inductively coded by three researchers. The inductive codes were then grouped into categories based on similarities which facilitated the emergence of themes.

resultsA total of 40 participants were interviewed between July 2024 and December 2024. Narrative analysis revealed three themes: (1)

conclusionsThis study revealed significant gaps in HPV knowledge and vaccination uptake among HIV-negative women and women living with HIV in Tennessee. Provider communication was key to vaccine decisions, but clear recommendations were often missed in clinical encounters.

Indexed as

Health Knowledge, Attitudes, PracticeHIV InfectionsHIV SeronegativityHuman Papillomavirus VirusesPapillomavirus InfectionsPapillomavirus VaccinesVaccinationAdolescentAdultFemaleHumansMiddle AgedProspective StudiesQualitative ResearchTennesseeYoung AdultPapillomavirus VaccinesHIV-negative womenHPVHPV vaccinequalitativestoriesUSwomen living with HIV

Identifiers

PMID42652293
PMCPMC13512212

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.